X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC PHARMA Fact Sheet, ALEMBIC PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Fact Sheet   (APLL)

Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC PHARMA Price History

Price Rs 616.2
Mkt Cap Rs m 116,166
Vol '000 2.5
P/E X 22.2
P/CF X 22.1
EPS (TTM) Rs 27.8
% ch % 0.3
No. of shares m 188.52
% ch week % 0.1
% ch 1-mth % 4.4
% ch 12-mth % 19.0
52 week H/L Rs 664.0/412.4
(As on Dec 11, 2018 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
ALEMBIC PHARMA EQUITY SHARE DATA
High Rs310495792709645 
Low Rs103228443516470 
Sales per share (Unadj.) Rs98.8109.1167.0166.3166.1 
Earnings per share (Unadj.) Rs12.515.038.221.421.9 
Diluted earnings per shareRs12.515.038.221.421.9 
Cash flow per share (Unadj.) Rs14.617.442.025.827.5 
Dividends per share (Unadj.) Rs3.003.504.004.004.00 
Adj. dividends per shareRs3.003.504.004.004.00 
Dividend yield (eoy) %1.51.00.60.70.7 
Book value per share (Unadj.) Rs35.846.984.9100.9117.8 
Adj. book value per shareRs35.846.984.9100.9117.8 
Shares outstanding (eoy) m188.52188.52188.52188.52188.52 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.13.33.73.73.4 
Avg P/E ratio x16.524.116.228.625.5 
P/CF ratio (eoy) x14.120.814.723.820.3 
Price / Book Value ratio x5.87.77.36.14.7 
Dividend payout %24.023.310.518.718.3 
Avg Mkt Cap Rs m38,93968,122116,383115,459105,090 
No. of employees `000NANANANANA 
Total wages/salary Rs m2,4703,0684,2145,5886,228 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC PHARMA INCOME DATA
Net Sales Rs m18,63220,56131,48731,34631,308 
Other income Rs m3223552070 
Total revenues Rs m18,66420,58431,54231,36631,378 
Gross profit Rs m3,5774,03010,0606,1536,431 
Depreciation Rs m4054447228301,055 
Interest Rs m9818375234 
Profit before tax Rs m3,1063,5919,3565,2915,413 
Minority Interest Rs m00000 
Prior Period Items Rs m02-2-38-81 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7517642,1601,2221,204 
Profit after tax Rs m2,3552,8297,1944,0314,128 
Gross profit margin %19.219.631.919.620.5 
Effective tax rate %24.221.323.123.122.2 
Net profit margin %12.613.822.812.913.2 
ALEMBIC PHARMA BALANCE SHEET DATA
Current assets Rs m7,0158,90715,06613,72518,247 
Current liabilities Rs m4,4746,8417,6746,92711,235 
Net working cap to sales %13.610.123.521.722.4 
Current ratio x1.61.32.02.01.6 
Inventory Days Days6168677486 
Debtors Days Days5464413961 
Net fixed assets Rs m4,1765,9478,23711,95720,035 
Share capital Rs m377377377377377 
"Free" reserves Rs m6,2358,37415,41618,64621,824 
Net worth Rs m6,7568,84616,00519,02322,201 
Long term debt Rs m522188005,000 
Total assets Rs m12,17316,41224,59426,89339,411 
Interest coverage x32.7202.7255.2102.2160.2 
Debt to equity ratio x0.10000.2 
Sales to assets ratio x1.51.31.31.20.8 
Return on assets %20.217.329.415.210.6 
Return on equity %34.932.044.921.218.6 
Return on capital %44.040.058.727.919.7 
Exports to sales %40.339.355.749.846.4 
Imports to sales %9.510.010.410.310.5 
Exports (fob) Rs m7,5028,08517,55115,62614,535 
Imports (cif) Rs m1,7652,0503,2833,2413,288 
Fx inflow Rs m7,7208,28417,81115,80614,722 
Fx outflow Rs m2,6283,1475,3185,2897,026 
Net fx Rs m5,0925,13712,49310,5177,696 
ALEMBIC PHARMA CASH FLOW
From Operations Rs m 2,400 1,718 9,304 3,286 3,124 
From Investments Rs m -811 -2,556 -3,105 -4,859 -8,844 
From Financial Activity Rs m -1,511 867 -1,959 -1,289 5,026 
Net Cashflow Rs m 79 29 4,240 -2,862 -693 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.9%
FIIs 9.1%
ADR/GDR 0.0%
Free float 13.9%
Shareholders 49,328
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, ,Vadodara,Gujarat - 390 003
E-MAIL apl.investors@alembic.co.in WEB www.alembic-india.com
TELEPHONE (0265) 2282 550 FAX (0265) 2282 506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Rajkumar Baheti YEAR OF INC: 2010 BSE CODE: 533573 FV (Rs): 2 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   ALKEM LABORATORIES  WYETH LTD  SANOFI INDIA  BIOCON LTD  VENUS REMEDIES  

Compare ALEMBIC PHARMA With:   ALKEM LABORATORIES  WYETH LTD  SANOFI INDIA  BIOCON LTD  VENUS REMEDIES  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Views on news

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS